A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.

Authors :: Karampeazis, A
Vamvakas, L.
Agelaki, Sofia
Kentepozidis, N
Papadimitraki, E
Gioulbasanis, I.
Vardakis, N
Ignatiadis, Michail
Mavroudis, Dimitris
Georgoulias, Vassilis
Karampeazis, A
Vamvakas, L.
Agelaki, Sofia
Kentepozidis, N
Papadimitraki, E
Gioulbasanis, I.
Vardakis, N
Ignatiadis, Michail
Mavroudis, Dimitris
Georgoulias, Vassilis
Source :: Oncology, 71 (5-6
Publication Year :: 2006
Abstract: To determine the maximum tolerated doses (MTDs) and the dose-limiting toxicities of a biweekly administration of oral vinorelbine and gemcitabine in patients with advanced solid tumors.<br />info:eu-repo/semantics/published

Tools